Hypertrophie bénigne de la prostateProstateIn the opinion of many urologists, prostate- specific antigen (PSA), which is not specific of any disease, is not considered in the diagnosis and follow-up of benign prostatic hyperplasia (BPH). Nonetheless, prostate cancer diagnosis is based on PSA ...
Traditionally, the role of hormonal therapy (HT) for prostate cancer (PCa) has been the palliative treatment of advanced and metastatic disease. Recently, advances in the development of androgen-deprivation therapy (ADT) with luteinising hormone-releasing hormone (LHRH) agonists have made LHRH ...
Dosage du PSA, biopsie, cancer et hypertrophie bénigne de la prostate en France[J] . P. Tuppin,S. Samson,A. Fagot-Campagna,B. Lukacs,F. Alla,H. Allemand,F. Paccaud,J.-C. Thalabard,é. Vicaut,M. Vidaud,B. Millat.Progres en Urologie . 2014...